Long-term safety and effectiveness of eculizumab in patients with AQP4+neuromyelitis optica spectrum disorder: 3 years of data from Japanese post-marketing surveillance

被引：0
|
作者：
Nakahara, Jin [1 ]
Nakashima, Ichiro [2 ]
Yokote, Hiroaki [3 ]
Manabe, Yasuhiro [4 ]
Okamura, Kazumi [5 ]
Hasegawa, Kou [5 ]
Fujihara, Kazuo [6 ,7 ]
机构：
[1] Keio Univ, Dept Neurol, Sch Med, Tokyo, Japan
[2] Tohoku Med & Pharmaceut Univ, Div Neurol, Sendai, Japan
[3] Tokyo Metropolitan Komagome Hosp, Dept Neurol, Tokyo, Japan
[4] Natl Hosp Org Okayama Med Ctr, Dept Neurol, Okayama, Japan
[5] Alexion Pharma GK, Tokyo, Japan
[6] Fukushima Med Univ, Fukushima, Japan
[7] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P010/1870
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Eculizumab in AQP4+neuromyelitis optica spectrum disorder: 3 years of data from Japanese post-marketing surveillance
    Nakahara, Jin
    Nakashima, Ichiro
    Yokote, Hiroaki
    Manabe, Yasuhiro
    Okamura, Kazumi
    Hasegawa, Kou
    Fujihara, Kazuo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [2] Eculizumab in AQP4+neuromyelitis optica spectrum disorder: 3 years of data from Japanese post-marketing surveillance
    Nakahara, J.
    Nakashima, I.
    Yokote, H.
    Manabe, Y.
    Okamura, K.
    Hasegawa, K.
    Fujihara, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 638 - 639
  • [3] Long-term efficacy and safety of eculizumab in aqp4+neuromyelitis optica spectrum disorder
    Wingerchuk, D.
    Berthele, A.
    Fujihara, K.
    Oreja-Guevara, C.
    Kim, H. J.
    Levy, M.
    Nakashima, I.
    Palace, J.
    Shang, S.
    Yountz, M.
    Miller, L.
    Pittock, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 465 - 465
  • [4] Long-term efficacy and safety of eculizumab monotherapy in AQP4+neuromyelitis optica spectrum disorder
    Pittock, S.
    Fujihara, K.
    Palace, J.
    Berthele, A.
    Kim, H. J.
    Oreja-Guevara, C.
    Nakashima, I.
    Levy, M.
    Pace, A.
    Yountz, M.
    Miller, L.
    Armstrong, R.
    Wingerchuk, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 1 - 1
  • [5] Long-term efficacy and safety of eculizumab monotherapy in AQP4+neuromyelitis optica spectrum disorder
    Pittock, Sean
    Fujihara, Kazuo
    Palace, Jacqueline
    Berthele, Achim
    Kim, Ho Jin
    Guevara, Celia Oreja
    Nakashima, Ichiro
    Levy, Michael
    Shang, Shulian
    Yountz, Marcus
    Miller, Larisa
    Armstrong, Roisin
    Wingerchuk, Dean
    NEUROLOGY, 2021, 96 (15)
  • [6] Safety and effectiveness of eculizumab in Japanese patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: interim analysis of post-marketing surveillance data
    Nakashima, I.
    Hoshino, Y.
    Okamura, K.
    Kikui, H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 791 - 792
  • [7] Long-term safety and effectiveness of eculizumab in neuromyelitis optica spectrum disorder
    Wingerchuk, D. M.
    Pittock, S. J.
    Berthele, A.
    Fujihara, K.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K-C.
    Allen, K.
    Fujita, K. P.
    Yountz, M.
    Armstrong, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 45 - 46
  • [8] Long-term Safety And Effectiveness Of Eculizumab In Neuromyelitis Optica Spectrum Disorder
    Wingerchuk, D.
    Pittock, S.
    Berthele, A.
    Fujihara, K.
    Kim, H.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K.
    Allen, K.
    Fujita, K. P.
    Yountz, M.
    Armstrong, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 107 - 107
  • [9] Safety and Effectiveness of Eculizumab in Japanese Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+NMOSD): Interim Analysis of a Post-Marketing Surveillance Study
    Nakahara, Jin
    Nakashima, Ichiro
    Yokote, Hiroaki
    Manabe, Yasuhiro
    Okamura, Kazumi
    Hasegawa, Kou
    Fujihara, Kazuo
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP25 - NP25
  • [10] Safety and Effectiveness of Eculizumab in Japanese Patients With Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance Study
    Nakashima, Ichiro
    Hoshino, Yo
    Okamura, Kazumi
    Kikui, Hidekazu
    Fujihara, Kazuo
    Edwards, Yuriy
    NEUROLOGY, 2022, 99 (23) : S2 - S3
12345